{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:13:39Z","timestamp":1793168019692,"version":"4.5.0"},"reference-count":108,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To organize, categorize, and create a quick reference guide for the use of intravitreal antibiotic alternatives to the standard combination of vancomycin and ceftazidime for the treatment of endophthalmitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. The authors searched for all available information regarding intravitreal antibiotics in the last 21 years. Manuscripts were selected according to relevance, level of information, and the available data regarding intravitreal dose, potential adverse effects, bacterial coverage, and relevant pharmacokinetic information.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The authors included 164 of 1810 manuscripts. The antibiotics were classified according to their class into fluoroquinolones, cephalosporins, glycopeptide and lipopeptide, penicillins and beta-lactams, tetracyclines, and miscellaneous. The authors also included information regarding intravitreal adjuvants for the treatment of endophthalmitis and one ocular antiseptic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The treatment of infectious endophthalmitis is a therapeutic challenge. The current review summarizes the properties of possible intravitreal antibiotic alternatives that should be considered in cases of suboptimal response to initial treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003773","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T22:03:35Z","timestamp":1678399415000},"page":"1433-1447","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["ALTERNATIVE INTRAVITREAL ANTIBIOTICS"],"prefix":"10.1097","volume":"43","author":[{"given":"Raul","family":"Velez-Montoya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Monroy-Esquivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Ortiz-Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Quiroz-Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jans","family":"Fromow-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For the Mexican Endophthalmitis Study Group (Mex-ESG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250605","first-page":"1","article-title":"Kocuria endophthalmitis: clinical spectrum and long-term outcomes","author":"Amadeo-Oreggioni","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/antibiotics10050527","article-title":"Antimicrobial susceptibility patterns and resistance trends of Staphylococcus aureus and coagulase-negative staphylococci strains isolated from ocular infections","volume":"10","author":"Petrillo","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00417-017-3608-y","article-title":"Microbial flora and resistance in ophthalmology: a review","volume":"255","author":"Grzybowski","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2147\/IDR.S314647","article-title":"Microbial spectrum and resistance patterns in ocular infections: a 15-year review in east China","volume":"14","author":"Liu","year":"2021","journal-title":"Infect Drug Resist"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40662-017-0083-9","article-title":"Sensitivity, specificity and predictive values of anterior chamber tap in cases of bacterial endophthalmitis","volume":"4","author":"Sjoholm-Gomez de Liano","year":"2017","journal-title":"Eye Vis"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.ophtha.2005.01.050","article-title":"Management and outcomes of postoperative endophthalmitis since the endophthalmitis vitrectomy study: the Endophthalmitis Population Study of Western Australia (EPSWA)'s fifth report","volume":"112","author":"Ng","year":"2005","journal-title":"Ophthalmology"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"xx","DOI":"10.1016\/j.ajo.2017.11.021","article-title":"Endophthalmitis: then and now","volume":"187","author":"Relhan","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.4103\/ijo.IJO_199_21","article-title":"Endophthalmitis management study. Report #1. Protocol","volume":"69","author":"Das","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archopht.126.4.559","article-title":"Legacy of the endophthalmitis vitrectomy study","volume":"126","author":"Flynn","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","article-title":"A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group","volume":"113","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/IAE.0000000000001603","article-title":"Emerging worldwide antimicrobial resistance, antibiotic stewardship and alternative intravitreal agents for the treatment of endophthalmitis","volume":"37","author":"Relhan","year":"2017","journal-title":"Retina"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/jama.2016.11764","article-title":"Antimicrobial resistance","volume":"316","author":"Marston","year":"2016","journal-title":"JAMA"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/OPTO.S189115","article-title":"Antibiotic resistance among ocular pathogens: current trends from the ARMOR surveillance study (2009\u20132016)","volume":"11","author":"Thomas","year":"2019","journal-title":"Clin Optom"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ajo.2008.01.025","article-title":"Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates","volume":"145","author":"Asbell","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/bjophthalmol-2015-307722","article-title":"Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment","volume":"100","author":"Relhan","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12348-014-0022-z","article-title":"Pharmacokinetics of intravitreal antibiotics in endophthalmitis","volume":"4","author":"Radhika","year":"2014","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1076\/ceyr.22.6.451.5486","article-title":"Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit","volume":"22","author":"Dajcs","year":"2001","journal-title":"Curr Eye Res"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.survophthal.2004.01.005","article-title":"Fluoroquinolones: mechanism of action, classification, and development of resistance","volume":"49","author":"Blondeau","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/jphp.12029","article-title":"Vitreous and aqueous penetration of intravitreally and orally administered moxifloxacin in an experimental rabbit model of fungal endophthalmitis","volume":"65","author":"Arikan","year":"2013","journal-title":"J Pharm Pharmacol"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000055570","article-title":"Ofloxacin levels after intravitreal injection","volume":"31","author":"Ozturk","year":"1999","journal-title":"Ophthalmic Res"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2174\/1381612822666161205105404","article-title":"Prevention and treatment of postoperative endophthalmitis using povidone-iodine","volume":"23","author":"Shimada","year":"2017","journal-title":"Curr Pharm Des"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.9.5.5","article-title":"Evaluation of retinal function and pathology after intravitreal injection of povidone-iodine and polyvinyl alcohol-iodine in rabbits","volume":"9","author":"Shimada","year":"2020","journal-title":"Translational Vis Sci Technol"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF00927265","article-title":"Toxicity and clearance of intravitreal cefotetan","volume":"228","author":"Philipp","year":"1990","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/bjo.2007.124768","article-title":"Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis","volume":"92","author":"Ferrer","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1620\/tjem.205.223","article-title":"Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model","volume":"205","author":"Ermis","year":"2005","journal-title":"Tohoku J Exp Med"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1167\/iovs.05-1124","article-title":"Clearance of intravitreal moxifloxacin","volume":"47","author":"Iyer","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R28-20250605","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/bjo.2003.017947","article-title":"An in vitro study on the compatibility and precipitation of a combination of ciprofloxacin and vancomycin in human vitreous","volume":"88","author":"Hui","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R29-20250605","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/APO.0b013e3182970cc9","article-title":"Efficacy of intravitreal levofloxacin 0.5% ophthalmic solution in treating Pseudomonas aeruginosa endophthalmitis on a rabbit model","volume":"2","author":"Aziza","year":"2013","journal-title":"Asia-Pacific J Ophthalmol"},{"key":"R30-20250605","first-page":"502","article-title":"Cefazolin levels after intravitreal injection. Effects of inflammation and surgery","volume":"31","author":"Ficker","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R31-20250605","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/00498254.2019.1624872","article-title":"Uptake and pharmacokinetics of cefuroxime in rabbits after intravitreal, intracameral, and topical dosing: relevance to human ocular injection of cefuroxime","volume":"50","author":"Jairam","year":"2020","journal-title":"Xenobiotica"},{"key":"R32-20250605","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/archopht.1993.01090060016001","article-title":"Physical incompatibility of vancomycin and ceftazidime for intravitreal injection","volume":"111","author":"Fiscella","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R33-20250605","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/bjo.84.1.117a","article-title":"Vancomycin and ceftazidime incompatibility upon intravitreal injection","volume":"84","author":"Lifshitz","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R34-20250605","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12886-020-01487-w","article-title":"Endogenous Endophthalmitis successfully treated with Intravitreal Povidone-iodine injection: a case report","volume":"20","author":"Tanaka","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"R35-20250605","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1167\/iovs.05-0702","article-title":"Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models","volume":"47","author":"Gao","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R36-20250605","first-page":"76","article-title":"Intravitreal clearance of moxifloxacin","volume":"103","author":"Iyer","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R37-20250605","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ajo.2018.01.030","article-title":"Vancomycin-associated hemorrhagic occlusive retinal vasculitis: a clinical-pathophysiological analysis","volume":"188","author":"Todorich","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R38-20250605","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/IAE.0b013e318207d1b9","article-title":"Intravitreal daptomycin: a safety and efficacy study","volume":"31","author":"Comer","year":"2011","journal-title":"Retina"},{"key":"R39-20250605","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/02713683.2014.941072","article-title":"Clearance of intravitreal daptomycin in uveitis-induced rabbit model","volume":"40","author":"Ozcimen","year":"2015","journal-title":"Curr Eye Res"},{"key":"R40-20250605","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/02713680802344690","article-title":"The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental bacillus cereus endophthalmitis","volume":"33","author":"Liu","year":"2008","journal-title":"Curr Eye Res"},{"key":"R41-20250605","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.exer.2004.10.004","article-title":"A comparison of intravitreal piperacillin\/tazobactam with ceftazidime in experimental Pseudomonas aeruginosa endophthalmitis","volume":"80","author":"Ozkiris","year":"2005","journal-title":"Exp Eye Res"},{"key":"R42-20250605","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/archopht.117.8.1058","article-title":"Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis","volume":"117","author":"Park","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R43-20250605","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archophthalmol.2011.2527","article-title":"Intravitreal daptomycin in a case of bilateral endogenous endophthalmitis","volume":"130","author":"Buzzacco","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"R44-20250605","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10792-015-0072-8","article-title":"Multidrug-resistant Pseudomonas aeruginosa endophthalmitis in a silicone oil-filled eye treated with piperacillin\/tazobactam: report of a case and review of literature","volume":"35","author":"Goel","year":"2015","journal-title":"Int Ophthalmol"},{"key":"R45-20250605","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/02713680490894180","article-title":"The efficacy of piperacillin\/tazobactam in experimental Pseudomonas aeruginosa endophthalmitis: a histopathological and microbiological evaluation","volume":"30","author":"Ozkiris","year":"2005","journal-title":"Curr Eye Res"},{"key":"R46-20250605","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.jcrs.2010.09.013","article-title":"Intravitreal piperacillin\/tazobactam in the management of multidrug-resistant Pseudomonas aeruginosa endophthalmitis","volume":"36","author":"Pathengay","year":"2010","journal-title":"J Cataract Refractive Surg"},{"key":"R47-20250605","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/IIO.0000000000000020","article-title":"Evidence for and against intravitreous corticosteroids in addition to intravitreous antibiotics for acute endophthalmitis","volume":"54","author":"Bui","year":"2014","journal-title":"Int Ophthalmol Clin"},{"key":"R48-20250605","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.4103\/ijo.IJO_1886_19","article-title":"Intravitreal piperacillin-tazobactam in endophthalmitis caused by Mycobacterium abscessus in silico ne-filled eye: a case report","volume":"68","author":"Suganeswari","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R49-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/169739","article-title":"Intravitreal ampicillin sodium for antibiotic-resistant endophthalmitis: Streptococcus uberis first human intraocular infection report","volume":"2010","author":"Velez-Montoya","year":"2010","journal-title":"J Ophthalmol"},{"key":"R50-20250605","doi-asserted-by":"crossref","first-page":"a027029","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: an overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R51-20250605","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.1994.01090130058017","article-title":"Aminoglycoside toxicity in the treatment of endophthalmitis","volume":"112","author":"Campochiaro","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R52-20250605","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1469-0691.2000.00058-2.x","article-title":"Pharmacodynamics of doxycycline","volume":"6","author":"Cunha","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"R53-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2365945","article-title":"Postoperative nocardia endophthalmitis and the challenge of managing with intravitreal amikacin","volume":"2016","author":"Lodhi","year":"2016","journal-title":"Case Rep Ophthalmological Med"},{"key":"R54-20250605","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","article-title":"Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics","volume":"133","author":"Mather","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R55-20250605","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4103\/ijo.IJO_809_17","article-title":"Management of multi drug resistant endogenous Klebsiella pneumoniae endophthalmitis with intravitreal and systemic colistin","volume":"66","author":"Sharma","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"R56-20250605","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.4103\/0301-4738.126991","article-title":"Successful use of intravitreal and systemic colistin in treating multidrug resistant Pseudomonas aeruginosa post-operative endophthalmitis","volume":"62","author":"Samant","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"R57-20250605","first-page":"373","article-title":"Safety of intravitreal quinupristin\/dalfopristin in an animal model","volume":"9","author":"Giordano","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"R58-20250605","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1442-9071.2011.02545.x","article-title":"Early intravitreal treatment of endogenous bacterial endophthalmitis","volume":"39","author":"Yonekawa","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"key":"R59-20250605","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/02713689008999567","article-title":"Tolerance of intravitreal povidone-iodine in rabbit eyes","volume":"9","author":"Whitacre","year":"1990","journal-title":"Curr Eye Res"},{"key":"R60-20250605","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000063838","article-title":"Intravitreal penetration of cefepime after systemic administration to humans","volume":"216","author":"Aras","year":"2002","journal-title":"Ophthalmologica"},{"key":"R61-20250605","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.bcp.2010.07.012","article-title":"On the retinal toxicity of intraocular glucocorticoids","volume":"80","author":"Torriglia","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"R62-20250605","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0002-9610(86)90477-0","article-title":"Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions","volume":"151","author":"Zamora","year":"1986","journal-title":"Am J Surg"},{"key":"R63-20250605","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"R64-20250605","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2165\/00003495-199958002-00002","article-title":"Mode of action of fluoroquinolones","volume":"58","author":"Hooper","year":"1999","journal-title":"Drugs"},{"key":"R65-20250605","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archopht.124.4.479","article-title":"In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates","volume":"124","author":"Miller","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R66-20250605","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/bjo.2004.054007","article-title":"Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin","volume":"89","author":"Vedantham","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R67-20250605","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00006982-199711000-00008","article-title":"Ofloxacin penetration into the eye after intravenous and topical administration","volume":"17","author":"Fiscella","year":"1997","journal-title":"Retina"},{"key":"R68-20250605","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ophtha.2003.09.042","article-title":"Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration","volume":"111","author":"Fiscella","year":"2004","journal-title":"Ophthalmology"},{"key":"R69-20250605","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s12325-008-0107-x","article-title":"Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy","volume":"25","author":"Scoper","year":"2008","journal-title":"Adv Ther"},{"key":"R70-20250605","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/jop.2011.0021","article-title":"Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone","volume":"27","author":"Sakalar","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"R71-20250605","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006982-200602000-00011","article-title":"Intravitreal toxicity of moxifloxacin","volume":"26","author":"Aydin","year":"2006","journal-title":"Retina"},{"key":"R72-20250605","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/ACI.0000000000000755","article-title":"Classifying cephalosporins: from generation to cross-reactivity","volume":"21","author":"Fernandez","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R73-20250605","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1517\/14728214.12.4.511","article-title":"Emerging cephalosporins","volume":"12","author":"Page","year":"2007","journal-title":"Expert Opin Emerging Drugs"},{"key":"R74-20250605","first-page":"1602","article-title":"Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys","volume":"24","author":"Barza","year":"1983","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R75-20250605","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1076\/soph.17.3.153.14787","article-title":"Antibiotic therapy in post-operative endophthalmitis","volume":"17","author":"Wang","year":"2002","journal-title":"Semin Ophthalmol"},{"key":"R76-20250605","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.oret.2020.11.015","article-title":"Outcomes of infectious endophthalmitis in patients with systemic antibiotic allergies to penicillins, cephalosporins, or vancomycin","volume":"5","author":"Meyer","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"R77-20250605","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00417-005-1182-1","article-title":"Effect of intravitreal dexamethasone on vitreous vancomycin concentrations in patients with suspected postoperative bacterial endophthalmitis","volume":"243","author":"Gan","year":"2005","journal-title":"Graefe's Archive Clin Exp Ophthalmol"},{"key":"R78-20250605","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000438961","article-title":"Antibiotics","volume":"55","author":"Hariprasad","year":"2016","journal-title":"Dev Ophthalmol"},{"key":"R79-20250605","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ajo.2012.02.015","article-title":"Antibiotic use and antimicrobial resistance","volume":"153","author":"Kim","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"R80-20250605","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ophtha.2016.11.042","article-title":"Vancomycin-associated hemorrhagic occlusive retinal vasculitis: clinical characteristics of 36 eyes","volume":"124","author":"Witkin","year":"2017","journal-title":"Ophthalmology"},{"key":"R81-20250605","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000444046","article-title":"Intravitreal daptomycin for recalcitrant postoperative endophthalmitis","volume":"7","author":"Sim","year":"2016","journal-title":"Case Rep Ophthalmol"},{"key":"R82-20250605","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/14787210.5.3.365","article-title":"Piperacillin\u2013tazobactam: a \u03b2-lactam\/\u03b2-lactamase inhibitor combination","volume":"5","author":"Gin","year":"2007","journal-title":"Expert Rev Anti-infective Ther"},{"key":"R83-20250605","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000077326","article-title":"Determination of nontoxic concentrations of piperacillin\/tazobactam for intravitreal application","volume":"36","author":"Ozkiris","year":"2004","journal-title":"Ophthalmic Res"},{"key":"R84-20250605","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0896-1549(05)70261-3","article-title":"Gentamicin and other antibiotic toxicitiy","volume":"14","author":"Thomas","year":"2001","journal-title":"Ophthalmol Clin North America"},{"key":"R85-20250605","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1167\/iovs.05-0604","article-title":"Acute aminoglycoside retinal toxicity in vivo and in vitro","volume":"46","author":"Hancock","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R86-20250605","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0025-7125(16)30039-6","article-title":"Tetracyclines","volume":"79","author":"Klein","year":"1995","journal-title":"Med Clin North America"},{"key":"R87-20250605","first-page":"223","article-title":"[Retinal toxicity of intravitreal doxycycline. A pilot study]","volume":"82","author":"Aydin","year":"2007","journal-title":"Arch Soc Esp Oftalmol"},{"key":"R88-20250605","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1179\/1120009X12Z.00000000018","article-title":"Intravitreal tigecycline treatment in experimental Acinetobacter baumannii endophthalmitis","volume":"24","author":"Horozoglu","year":"2012","journal-title":"J Chemother"},{"key":"R89-20250605","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00417-014-2784-2","article-title":"Pharmacokinetics of intravenously administered tigecycline in eye compartments: an experimental study","volume":"252","author":"Ozcimen","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R90-20250605","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/505494","article-title":"Tigecycline: a critical analysis","volume":"43","author":"Stein","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R91-20250605","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria","volume":"33","author":"Evans","year":"1999","journal-title":"Ann Pharmacother"},{"key":"R92-20250605","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/FTD.0000000000000172","article-title":"Colistin: revival of an old polymyxin antibiotic","volume":"37","author":"Dijkmans","year":"2015","journal-title":"Ther Drug Monit"},{"key":"R93-20250605","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R94-20250605","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1167\/iovs.09-4244","article-title":"The safety of intraocular linezolid in rabbits","volume":"51","author":"Duke","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R95-20250605","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1136\/bjo.2005.073700","article-title":"The pharmacokinetics of linezolid in the non-inflamed human eye","volume":"89","author":"Prydal","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R96-20250605","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/09273948.2016.1245758","article-title":"A review of the role of intravitreal corticosteroids as an adjuvant to antibiotics in infectious endophthalmitis","volume":"26","author":"Ching Wen Ho","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R97-20250605","first-page":"CD012131","article-title":"Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure","volume":"2","author":"Kim","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R98-20250605","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ajo.2005.11.043","article-title":"Intravitreal triamcinolone acetonide in the management of exogenous bacterial endophthalmitis","volume":"141","author":"Pathengay","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R99-20250605","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1752-1947-5-130","article-title":"Quinupristin\/dalfopristin in Staphylococcus aureus endophthalmitis: a case report","volume":"5","author":"Hernandez-Da Mota","year":"2011","journal-title":"J Med Case Rep"},{"key":"R100-20250605","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1136\/bjo.2010.187963","article-title":"Adjunctive use of intravitreal dexamethasone in presumed bacterial endophthalmitis: a randomised trial","volume":"95","author":"Albrecht","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R101-20250605","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00006982-200605000-00008","article-title":"Role of intravitreal triamcinolone acetonide in the treatment of postoperative endophthalmitis","volume":"26","author":"Falk","year":"2006","journal-title":"Retina"},{"key":"R102-20250605","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/bjo.83.9.1050","article-title":"Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study","volume":"83","author":"Das","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"R103-20250605","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/ICU.0000000000000437","article-title":"The use of povidone-iodine in ophthalmology","volume":"29","author":"Grzybowski","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"R104-20250605","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5935\/0004-2749.20190098","article-title":"Effects of antibiotics and antiseptics on conjunctival bacterial flora in patients undergoing intravitreal injections","volume":"82","author":"Kanclerz","year":"2019","journal-title":"Arquivos Brasileiros de Oftalmologia"},{"key":"R105-20250605","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000217721","article-title":"The efficacy of intravitreal povidone iodine application in experimental Staphylococcus epidermidis endophthalmitis","volume":"41","author":"Brozou","year":"2009","journal-title":"Ophthalmic Res"},{"key":"R106-20250605","doi-asserted-by":"crossref","first-page":"108788","DOI":"10.1016\/j.exer.2021.108788","article-title":"Efficacy of intravitreal povidone-iodine administration for the treatment of Candida albicans endophthalmitis in rabbits","volume":"212","author":"Lee","year":"2021","journal-title":"Exp Eye Res"},{"key":"R107-20250605","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1167\/iovs.15-17739","article-title":"Intraocular pharmacokinetics of povidone-iodine and its effects on experimental Staphylococcus epidermidis endophthalmitis","volume":"56","author":"Kim","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R108-20250605","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/IAE.0000000000000634","article-title":"Vitrectomy using 0.025% povidone-iodine in balanced salt solution plus for the treatment of postoperative endophthalmitis","volume":"35","author":"Nakashizuka","year":"2015","journal-title":"Retina"},{"key":"R109-20250605","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/jop.2006.0076","article-title":"The effect of intravitreally injected povidone-iodine on Staphylococcus epidermidis in rabbit eyes","volume":"23","author":"Trost","year":"2007","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:07:53Z","timestamp":1749143273000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003773"}},"subtitle":["A Systematic Review for Consideration in Recalcitrant or Resistant Endophthalmitis"],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":108,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003773","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}